For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

The aim of Steven de Taeys’s research is to contribute to developing a vaccine that provides protection against the most important circulating strains of HIV. The only target for neutralising antibodies is the trimeric envelope glycoprotein GP120, an exposed glycoprotein of the surface of the HIV envelope. De Taeye explores various ways to improve the stability and antigenicity of HIV-1 Envelope trimers to enhance their performance as immunogens.

Event details of Inducing neutralising antibodies for HIV prevention
Date 9 March 2017
Time 14:00 -15:00
Location Agnietenkapel
Room Location

S.W. de Taeye: Stabilization of HIV-1 Envelope Glycoprotein Trimers to Induce Neutralizing Antibodies.


Prof. B. Berkhout

Prof. R.W. Sanders


Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam


This event is open to the public.